The Trademark Trial and Appeal Board affirmed the Trademark Office’s refusal of CBH International LLC’s application to register the composite word-and-design mark depicted above for CBD-based transdermal patches. Although CBH argued that its goods could be sold legally without going through the FDA approval process applicable to drugs, the TTAB disagreed, and therefore concluded that CBH lacked a bona fide intent to use its mark in legal commerce. CBH’s application covered the following goods:
